日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

E7(11-19) placement and orientation dictate CD8(+) T cell response in structurally defined spherical nucleic acid vaccines

E7(11-19) 的位置和方向决定了结构明确的球形核酸疫苗中的 CD8(+) T 细胞反应。

Hwang, Jeongmin; Ocampo, Tonatiuh A; Mayer, Vinzenz; Kang, Janice; Paranandi, Krishna S; Kim, Young Jun; Han, Zhenyu; Cavaliere, John P; Kudruk, Sergej; Lorch, Jochen H; Mirkin, Chad A

33 Unresolved Questions in Nanoscience and Nanotechnology

纳米科学与纳米技术领域33个尚未解决的问题

Mirkin, Chad A; Petrosko, Sarah Hurst; Artzi, Natalie; Aydin, Koray; Biaggne, Austin; Brinker, C Jeffrey; Bujold, Katherine E; Cao, Y Charles; Chan, Rachel R; Chen, Chaojian; Chen, Peng-Cheng; Chen, Xiaodong; Chevalier, Olivier J G L; Choi, Chung Hang Jonathan; Crooks, Richard M; Dravid, Vinayak P; Du, Jingshan S; Ebrahimi, Sasha B; Fan, Hongyou; Farha, Omar K; Figg, C Adrian; Fink, Tanner D; Forsyth, Connor M; Fuchs, Harald; Geiger, Franz M; Gianneschi, Nathan C; Gibson, Kyle J; Ginger, David S; Guo, SiShi; Hanes, Justin S; Hao, Liangliang; Huang, Jin; Hunter, Bryan M; Huo, Fengwei; Hwang, Jeongmin; Jin, Rongchao; Kelley, Shana O; Kempa, Thomas J; Kim, Youngeun; Kudruk, Sergej; Kumari, Sneha; Landy, Kaitlin M; Lee, Ki-Bum; Leon, Noel J; Li, Jun; Li, Yuanwei; Li, Zhiwei; Liu, Bin; Liu, Guoliang; Liu, Xiaogang; Liz-Marzán, Luis M; Lorch, Jochen H; Luo, Taokun; Macfarlane, Robert J; Millstone, Jill E; Mrksich, Milan; Murphy, Catherine J; Naik, Rajesh R; Nel, Andre E; Oetheimer, Christopher; Hedlund Orbeck, Jenny K; Park, So-Jung; Partridge, Benjamin E; Peppas, Nicholas A; Personick, Michelle L; Raj, Arindam; Ramani, Namrata; Ross, Michael B; Ross, Stacey Barnaby; Sargent, Edward H; Sengupta, Tanushri; Schatz, George C; Seferos, Dwight S; Seideman, Tamar; Seo, Soyoung Eileen; Shen, Bo; Shim, Wooyoung; Shin, Donghoon; Simon, Ulrich; Sinegra, Andrew J; Smith, Peter T; Spokoyny, Alexander M; Stang, Peter J; Stegh, Alexander H; Stoddart, J Fraser; Swearer, Dayne F; Tan, Weihong; Teplensky, Michelle H; Thaxton, C Shad; Walt, David R; Wang, Mary X; Wang, Zhe; Wei, Wei David; Weiss, Paul S; Winegar, Peter H; Xia, Younan; Xie, Yi; Xu, Xiaoyang; Yang, Peidong; Yang, Yiming; Ye, Zihao; Yoon, Kuk Ro; Zhang, Cuizheng; Zhang, Hua; Zhang, Ke; Zhang, Liangfang; Zhang, Xiaoyu; Zhang, Ye; Zheng, Zijian; Zhou, Wenjie; Zhu, Shengshuang; Zhu, Wei

Are all programmed cell death protein 1 inhibitors the same?

所有程序性细胞死亡蛋白1抑制剂都一样吗?

Lorch, Jochen H; Stein, Stacey; Edelman, Martin J

Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial

双重免疫检查点抑制剂治疗侵袭性甲状腺癌患者:一项 II 期非随机临床试验

Sehgal, Kartik; Pappa, Theodora; Shin, Kee-Young; Schiantarelli, Julia; Liu, Mofei; Ricker, Cora; Besson, Naomi R; Jones, Stephanie M; Welsh, Emma L; Pfaff, Kathleen L; Barletta, Justine A; Park, Jihye; Reardon, Brendan; Doherty, Gerard M; Alexander, Erik K; Rodig, Scott J; Barbie, David A; O'Neill, Anne; Van Allen, Eliezer; Haddad, Robert I; Lorch, Jochen H

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

纳武利尤单抗和利利尤单抗用于复发性、可切除的头颈部鳞状细胞癌患者的新辅助和辅助治疗

Hanna, Glenn J; O'Neill, Anne; Shin, Kee-Young; Wong, Kristine; Jo, Vickie Y; Quinn, Charles T; Cutler, Jennifer M; Flynn, Michelle; Lizotte, Patrick H; Annino, Donald J Jr; Goguen, Laura A; Kass, Jason I; Rettig, Eleni M; Sethi, Rosh K V; Lorch, Jochen H; Schoenfeld, Jonathan D; Margalit, Danielle N; Tishler, Roy B; Everett, Peter C; Desai, Anupam M; Cavanaugh, Megan E; Paweletz, Cloud P; Egloff, Ann Marie; Uppaluri, Ravindra; Haddad, Robert I

A Robust Method for Perfusable Microvascular Network Formation In Vitro

一种用于体外构建可灌注微血管网络的稳健方法

Wan, Zhengpeng; Zhong, Amy X; Zhang, Shun; Pavlou, Georgios; Coughlin, Mark F; Shelton, Sarah E; Nguyen, Huu Tuan; Lorch, Jochen H; Barbie, David A; Kamm, Roger D

Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid Cancer

铂类化疗对继发性甲状腺癌的突变影响

Schiantarelli, Julia; Pappa, Theodora; Conway, Jake; Crowdis, Jett; Reardon, Brendan; Dietlein, Felix; Huang, Julian; Stanizzi, Darren; Carey, Evan; Bosma-Moody, Alice; Imamovic, Alma; Han, Seunghun; Camp, Sabrina; Kofman, Eric; Shannon, Erin; Barletta, Justine A; He, Meng Xiao; Liu, David; Park, Jihye; Lorch, Jochen H; Van Allen, Eliezer M

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19

头颈癌患者和新冠肺炎幸存者的住院率和30天全因死亡率

Hanna, Glenn J; Rettig, Eleni M; Park, Jong C; Varvares, Mark A; Lorch, Jochen H; Margalit, Danielle N; Schoenfeld, Jonathan D; Tishler, Roy B; Goguen, Laura A; Annino, Donald J Jr; Haddad, Robert I; Uppaluri, Ravindra

The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers

曲妥珠单抗辅助治疗对HER-2阳性唾液腺癌的益处

Hanna, Glenn J; Bae, Ji Eun; Lorch, Jochen H; Haddad, Robert I; Jo, Vickie Y; Schoenfeld, Jonathan D; Margalit, Danielle N; Tishler, Roy B; Goguen, Laura A; Annino, Donald J Jr; Chau, Nicole G

The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature

检查点抑制剂在移植受者中的安全性和有效性:病例系列及文献系统综述

Kumar, Vivek; Shinagare, Atul B; Rennke, Helmut G; Ghai, Sandeep; Lorch, Jochen H; Ott, Patrick A; Rahma, Osama E